No-see, no-handle needle
No reconstitution required
No need to dial a dose

Yes, I think I can do this

Patients will need additional assistance from their healthcare professional as well as reviewing the full Instructions for Use included with the Trulicity Pen.

Learn More

*In clinical studies, the range of A1C reduction from baseline was 0.7% to 1.6% for the 0.75 mg dose and 0.8% to 1.6% for the 1.5 mg dose.1,2

Recommended starting dose is 0.75 mg. Dose can be increased to 1.5 mg.

For more information on clinical trials, click here.

In a study, 94% of people said the Trulicity Pen was easy to use.3 People with type 2 diabetes, caregivers of people with diabetes, and healthcare professionals who treat diabetes participated in a study on the safe and effective use of the Trulicity Pen and the instructions for the Trulicity Pen. One hundred and twenty-seven of 128 people completed a questionnaire on their experience using the pen and the instructions. One of the questions asked in the questionnaire included, “overall easy to use the medication delivery device.”

Indication and Important Safety Information 
WARNING: POTENTIAL RISK OF THYROID TUMORS INCLUDING THYROID CANCER

Indication and Important Safety Information 
WARNING: POTENTIAL RISK OF THYROID TUMORS INCLUDING THYROID CANCER

Back to top